Woman and Man
- | Country :
- Japan
- | organs : -
- | Specialty : -
Extract
To investigate the safety, pharmacokinetics, and efficacy following 30-minute continuous intravenous administration of OPC-108459 at 0.4, 0.8, 1.6, or 2.4 mg/kg or placebo to patients with paroxysmal or persistent atrial fibrillation
Inclusion criteria
- Atrial fibrillation